Factor | Coefficient | Adjusted OR (95% CI) | p value | Risk score |
---|---|---|---|---|
Body mass index (Ref: 15-24.9) | ||||
5–14.9 | 0.51 | 1.66 (1.07, 2.58) | 0.024 | 1 |
25-60 | 1.04 | 2.82 (1.30, 6.11) | 0.009 | 2 |
Hyper-reactive airway (Ref: No) | ||||
Yes | 0.92 | 2.50 (1.12, 5.59) | 0.025 | 2 |
Probable difficult airway (Ref: No) | ||||
Yes | 1.61 | 4.99 (1.74, 14.32) | 0.003 | 3 |
ASA physical status (Ref: 1) | ||||
2 | 0.31 | 1.36 (0.73, 2.53) | 0.327 | 0 |
3 | 1.55 | 4.73 (2.43, 9.18) | <0.001 | 3 |
Site/ type of procedure (Ref: Eye) | ||||
Urologic | 1.46 | 4.32 (1.39, 13.41) | 0.01 | 3 |
Airway | 2.04 | 7.72 (2.62, 22.70) | 0.0002 | 4 |
Ear-nose-face | 0.82 | 2.27 (0.60, 8.52) | 0.22 | 0 |
Thoracic | 5.63 | 277.9 (44.56, 1733) | <0.0001 | 11 |
Intra-abdomen | 1.96 | 7.12 (2.30, 22.04) | 0.0007 | 4 |
Orthopedic | 1.95 | 7.00 (2.30, 21.33) | 0.0006 | 4 |
Intra-cranial | 2.01 | 7.45 (1.62, 34.20) | 0.01 | 4 |
Gastrointestinal scope | 1.23 | 3.42 (0.88, 13.37) | 0.07 | 0 |
Cardiac catheterization | 1.98 | 7.28 (2.04, 25.96) | 0.002 | 4 |
Airway device (Ref: Facemask/LMA) | ||||
Spontaneous breathing with non- rebreathing mask | 1.38 | 3.98 (0.64, 24.88) | 0.14 | 0 |
Endotracheal tube intubation | 1.89 | 6.64 (2.54, 17.32) | 0.0001 | 4 |
Neuromuscular blocking agent (Ref: None) | ||||
Succinylcholine | 0.67 | 1.95 (0.92, 4.13) | 0.080 | 0 |
Aminosteroid derivatives | 1.06 | 2.89 (1.18, 7.05) | 0.02 | 2 |
Benzylisoquinolines | 0.07 | 1.07 (0.58, 1.96) | 0.83 | 0 |
Anesthetic time (hours) (Ref: <1) | ||||
1–2.9 | 1.09 | 2.99 (1.38, 6.44) | 0.005 | 2 |
≥3 | 1.57 | 4.79 (1.99, 11.6) | 0.0005 | 3 |
PRAE (Ref: None) | ||||
UAO and laryngospasm | 4.12 | 61.5 (14.4, 262) | <0.0001 | 8 |
Desaturation | 6.18 | 481.2 (177.9, 1302) | <0.0001 | 12 |
Bronchospasm/wheezing | 4.53 | 92.4 (29.7, 288) | <0.0001 | 9 |